Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (1)
  • 2022 (7)
  • 2021 (1)
  • 2019 (1)
  • 2017 (2)

Subject

  • Take Back Day (24)
  • Drug Trafficking (23)
  • Prescription Drugs (19)
  • Outreach/Drug Prevention (18)
  • Public and Media Affairs - also see Congressional Affairs (16)
  • Congressional Affairs (12)
  • Press Conferences (11)
  • Fake Pills (9)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • Arrests/Convictions - Major (8)
  • Red Ribbon (8)
  • Diversion Division (7)
  • Fentanyl Awareness (7)
  • Major Law Enforcement Operation (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (6)
  • Guns/Weapons (5)
  • Money Laundering (5)
  • OCDETF/Task Force (5)
  • One Pill Can Kill (5)
  • Intergovernmental Affairs (4)
  • Critical Incident (3)
  • Extraditions (3)
  • International/Foreign Operations (3)
  • Narcoterrorism (3)
  • Seizures (Drugs/Property) (3)
  • Gangs (2)
  • Scam Calls (2)
  • Dark Web- Internet Trafficking (1)
  • HIDTA (1)
  • Museum and Visitors Center (1)
  • Task Forces/Task Force Officers (1)
  • Synthetic drugs (11)
  • Overdose (3)

Drug Name

  • Fentanyl (10)
  • Methamphetamine (2)
  • Oxycodone (1)

Field Division

  • Seattle (246)
  • Washington, DC (180)
  • New York (175)
  • San Francisco (103)
  • El Paso (67)
  • Houston (59)
  • Chicago (55)
  • Atlanta (34)
  • St. Louis (31)
  • San Diego (29)
  • Miami (24)
  • New Jersey (22)
  • Los Angeles (20)
  • Dallas (17)
  • Omaha (11)
  • Phoenix (7)
  • Louisville (5)
  • New England (3)
  • New Orleans (3)
  • Rocky Mountain (3)
  • Philadelphia (2)
  • Detroit (1)
  • Headquarters (12)
Clear All Results
PRESS RELEASE

DEA Releases 2024 National Drug Threat Assessment

May 09, 2024
WASHINGTON – Today, DEA Administrator Anne Milgram announced the release of the 2024 National Drug Threat Assessment (NDTA), DEA’s comprehensive strategic assessment of illicit drug threats and trafficking trends endangering the United States. For more than a decade, DEA’s NDTA has been a trusted resource for law enforcement agencies, policy...
May 09, 2024
PRESS RELEASE

DEA Announces Significant Fentanyl Seizure in New York

October 13, 2022
WASHINGTON – Yesterday, DEA and the Office of the Special Narcotics Prosecutor for the City of New York announced a significant seizure of fentanyl. Two individuals in New York have been charged following the seizure of approximately 300,000 rainbow fentanyl pills, 20 pounds of fentanyl in white and blue powder...
October 13, 2022
PRESS RELEASE

DEA Announces Results of Enforcement Surge to Reduce the Fentanyl Supply Across the United States

September 27, 2022
WASHINGTON – The U.S. Drug Enforcement Administration today announced the results of an enforcement operation that spanned from May to September and resulted in significant fentanyl seizures across the United States. As part of the One Pill Can Kill initiative, the DEA and its law enforcement partners seized more than...
September 27, 2022
PRESS RELEASE

DEA Warns of Brightly-Colored Fentanyl Used to Target Young Americans

August 30, 2022
WASHINGTON – The Drug Enforcement Administration is advising the public of an alarming emerging trend of colorful fentanyl available across the United States. Since August 2022, DEA and our law enforcement partners seized brightly-colored fentanyl and fentanyl pills in 26 states. Dubbed “rainbow fentanyl” in the media, this trend appears...
August 30, 2022
PRESS RELEASE

DEA Holds Inaugural Family Summit on the Overdose Epidemic

June 15, 2022
WASHINGTON – On June 14 and 15, DEA Administrator Anne Milgram hosted the first-ever DEA Family Summit on the Overdose Epidemic for families from across the country who have experienced the profound loss of a child due to a drug overdose or poisoning. Deputy Attorney General Lisa O. Monaco delivered...
June 15, 2022
PRESS RELEASE

DEA Recognizes First Ever National Fentanyl Awareness Day

May 09, 2022
WASHINGTON – In an effort to save lives, DEA is proud to join “Song for Charlie” and many of our valued public health, non-profit, and law enforcement partners in recognizing the first ever National Fentanyl Awareness Day. This day is an effort to educate individuals around the dangerous threat that...
May 09, 2022
PRESS RELEASE

President Biden Releases National Drug Control Strategy to Save Lives, Expand Treatment, and Disrupt Trafficking

April 21, 2022
WASHINGTON, D.C. – Today, President Joe Biden sent his Administration’s inaugural National Drug Control Strategy to Congress at a time when drug overdoses have reached a record high. The Strategy delivers on the call to action in President Biden’s Unity Agenda through a whole-of-government approach to beat the overdose epidemic...
April 21, 2022
PRESS RELEASE

DEA Warns of Increase in Mass-Overdose Events Involving Deadly Fentanyl

April 06, 2022
WASHINGTON – Today, the Drug Enforcement Administration sent a letter to federal, state, and local law enforcement partners warning of a nationwide spike in fentanyl-related mass-overdose events. Administrator Anne Milgram outlined the current threat and offered DEA support to law enforcement officers responding to these tragic incidents. “Fentanyl is killing...
April 06, 2022
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
September 27, 2021
PRESS RELEASE

Five Estonian residents arrested for conspiring to import carfentanil and fentanyl into the United States

May 09, 2019
WASHINGTON – Christopher T. Tersigni, Special Agent in Charge of the Special Operations Division of the U.S. Drug Enforcement Administration, and Geoffrey S. Berman, the U.S. Attorney for the Southern District of New York, today announced that Estonian residents Jevgeni Bokov, Viktor Litvintsuk, Amid Magerramov, Nikolai Niftalijev, and Vitali Voronjuk...
May 09, 2019
Showing 1 - 10 of 12 results

Pagination

  • Current page 1
  • Page 2
  • Next page ›
  • Last page »

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español